Inventor · disambiguated record
Satish Jindal
Also filed as: JINDAL SATISH
7 granted patents·2 pending applications·139 citations·filing 1998–2007
85Inventor score
Files withPERSEPTIVE BIOSYSTEMS INC2SCHERING CORP2BIOGEN INC1NEOGENESIS DRUG DISCOVERY INC1NEOGENESIS INC1
Top patents by PatentIndex Score
9 records- 0184US7173046B2CD40:CD154 binding interrupter compounds and use thereof to treat immunological complicationsBIOGEN INC·Filed 2003·Granted Feb 6, 2007·22 cites·6 claims
- 0284US6358692B1High speed, automated, continuous flow, multi-dimensional molecular selection and analysisPERSEPTIVE BIOSYSTEMS INC·Filed 1999·Granted Mar 19, 2002·69 cites·19 claims
- 0377US6794148B2High speed, automated, continuous flow, multi-dimensional molecular selection and analysisPERSEPTIVE BIOSYSTEMS INC·Filed 2001·Granted Sep 21, 2004·15 cites·18 claims
- 0468US6207861B1Method for producing and screening mass coded combinatorial libraries for drug discovery and target validationNEOGENESIS INC·Filed 1998·Granted Mar 27, 2001·30 cites·15 claims
- 0562US7269519B2Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validationSCHERING CORP·Filed 2003·Granted Sep 11, 2007·0 cites·23 claims
- 0650US2007249682A1Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complicationsZHENG ZHONGLI·Filed 2007·Application pending·0 cites
- 0748US2006063169A1Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validationNEOGENESIS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 0845US7169563B2Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validationSCHERING CORP·Filed 2002·Granted Jan 30, 2007·0 cites·11 claims
- 0935US6714875B1Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validationNEOGENESIS DRUG DISCOVERY INC·Filed 1999·Granted Mar 30, 2004·3 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →